Skip to main content
. 2015 Dec 18;36(2):182–184. doi: 10.3343/alm.2016.36.2.182

Table 1. Clinical features and laboratory findings of patients with congenital factor V deficiency in Korea.

Case Relationship Age/Sex Bleeding episodes Bleeding severity PT (sec) (N/I) aPTT (sec) (N/I) FV activity (%) Mutations Reference
1 Proband 14/F Hematuria, menorrhagia Grade II 15.4 (I) 48.1 (I) 41 p.(Asp96His) Present study
 1-1 Mother 40/F Asymptomatic 14.1 (N) 37.9 (N) 44 p.(Asp96His) Present study
2 Proband 51/F Easy bruisability Grade II 40.9 (I) 106.0 (I) 3 p.[(Asn2010_Ser2011del)];[(Arg2202Cys)] Present study
 2-1 Daughter 21/F Suspected hematoma Grade III 12.6 (N) 35.0 (N) 39 p.(Asn2010_Ser2011del) Present study
3 Proband 9/M Hemarthrosis Grade III 36.0 (I) 110.0 (I) 6 Not tested 1987 [7]
4 Proband 25/M Prolonged bleeding after tooth extraction Grade I 35.7 (I) 111.7 (I) 4 p.[(Arg1161*)];[(Asn2010_Ser2011del)] 2009 [3]
 4-1 Twin brother 25/M Prolonged bleeding after tooth extraction Grade I 33.1 (I) 103.2 (I) 5 p.[(Arg1161*)];[(Asn2010_Ser2011del)] 2009 [3]
 4-2 Sister 1 ?/F Asymptomatic 14.9 (N) 42.5 (N) 45 p.(Arg1161*) 2009 [3]
 4-3 Sister 2 ?/F Asymptomatic 15.1 (I) 46.6 (I) 50 p.(Asn2010_Ser2011del) 2009 [3]

Abbreviations: PT, prothrombin time; aPTT, activated partial thromboplastin time; N, within normal range; I, increased time than reference range; FV, factor V.